Chronic Disease Medicines & Devices

The thesis

Own the medicines and medical devices used to manage persistent metabolic, cardiovascular and immune disorders, where ongoing treatment supports recurring demand. The basket offers an alternative to AI infrastructure exposure, with its liquid core drawn from drugmakers and Medtronic and complemented by diabetes specialists. Recent healthcare strength supports the timing, but reimbursement pressure, clinical setbacks and elevated expectations remain meaningful risks.